Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Exploring nonviral nanocarriers as RNA delivery platforms for the treatment of breast cancer

Sun, Zhuokai, Martin, Tracey A. ORCID: https://orcid.org/0000-0003-2690-4908 and Jiang, Wen G. ORCID: https://orcid.org/0000-0002-3283-1111 2026. Exploring nonviral nanocarriers as RNA delivery platforms for the treatment of breast cancer. Chemical Engineering Journal 538 , 176496. 10.1016/j.cej.2026.176496

[thumbnail of 1-s2.0-S1385894726039574-main.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (17MB) | Preview

Abstract

Breast cancer is a highly heterogeneous malignancy that requires increasingly precise and individualized therapeutic strategies. RNA-based therapeutics, such as small interfering RNA(siRNA), microRNA(miRNA), messenger RNA(mRNA), and CRISPR-associated systems, enable precise regulation of tumour-associated genes, offering targeted breast cancer treatment with enhanced efficacy and reduced off-target toxicity. However, their clinical translation is hindered by poor stability, rapid degradation, and limited delivery efficiency in vivo. Non-viral nanocarriers have emerged as promising platforms to address these limitations due to their structural tunability, low immunogenicity, and high transfection efficiency. In this review, we systematically summarize recent advances in non-viral nanocarriers for RNA delivery in breast cancer treatment, covering major carrier classes including polymer-based, lipid-based, inorganic, and hybrid systems. A comparative framework is established to evaluate these nanocarriers based on cargo loading strategies, targeting mechanisms, endosomal escape efficiency, therapeutic performance, and translational barriers. Furthermore, we discuss how tumour heterogeneity and subtype-specific characteristics inform the rational design of RNA delivery systems within a precision medicine context. This review aims to provide a structured understanding of non-viral nanocarrier design principles and to offer guidance for the development of next-generation RNA delivery platforms for breast cancer therapy.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Medicine
Additional Information: RRS applied 24/02/2026 AB
Publisher: Elsevier
ISSN: 1385-8947
Date of First Compliant Deposit: 21 April 2026
Date of Acceptance: 20 April 2026
Last Modified: 06 May 2026 10:17
URI: https://orca.cardiff.ac.uk/id/eprint/186516

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics